secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2022-12-19T23:59:59+00:00
Accession:  0001654954-22-016650
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA Life Sciences extends collaborative research agreement with GE through Dec 2024
--------------------------------------------------------------------------------

- Amendment 5 extends the term of the GE collaboration to December 16, 2024.
- Original agreement dated April 22, 2016; this is the fifth amendment.
- No financial terms disclosed; the amendment is filed as Exhibit 10.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495422016650/0001654954-22-016650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495422016650/endra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-016650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer